Publications by: Megan Lyle

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0 [feed] RSS 2.0
Number of items: 2.

Weppler, Alison M., Da Meda, Laetitia, Pires da Silva, Ines, Xu, Wen, Grignani, Giovanni, Menzies, Alexander M., Carlino, Matteo S., Long, Georgina V., Lo, Serigne N., Nordman, Ina, Steer, Christopher B., Lyle, Megan, Trojaniello, Claudia, Ascierto, Paolo A., Lebbe, Celeste, and Sandhu, Shahneen (2023) Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation. European Journal of Cancer, 183. pp. 109-118.

Pires da Silva, Ines, Ahmed, Tasnia, Reijers, Irene L.M., Weppler, Alison M., Betof Warner, Allison, Patrinely, James Randall, Serra-Bellver, Patricio, Allayous, Clara, Mangana, Joanna, Nguyen, Khang, Zimmer, Lisa, Trojaniello, Claudia, Stout, Dan, Lyle, Megan, Klein, Oliver, Gerard, Camille L., Michielin, Olivier, Haydon, Andrew, Ascierto, Paolo A., Carlino, Matteo S., Lebbe, Celeste, Lorigan, Paul, Johnson, Douglas B., Sandhu, Shahneen, Lo, Serigne N., Blank, Christian U., Menzies, Alexander M., and Long, Georgina V. (2021) Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study. The Lancet Oncology, 22 (6). pp. 836-847.

This list was generated on Wed May 22 18:49:21 2024 AEST.